PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $302,000 | -23.5% | 83,500 | -28.0% | 0.04% | -31.4% |
| Q3 2019 | $395,000 | -27.5% | 116,000 | 0.0% | 0.05% | +34.2% |
| Q2 2019 | $545,000 | -44.3% | 116,000 | -60.3% | 0.04% | -15.6% |
| Q1 2019 | $979,000 | +2.2% | 292,500 | -18.8% | 0.04% | -31.8% |
| Q4 2018 | $958,000 | +24.3% | 360,343 | +161.6% | 0.07% | +50.0% |
| Q3 2018 | $771,000 | -18.1% | 137,748 | -25.8% | 0.04% | -20.0% |
| Q2 2018 | $941,000 | +1263.8% | 185,700 | +514.9% | 0.06% | +511.1% |
| Q4 2015 | $69,000 | – | 30,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |